Jazz Pharmaceuticals plc — Director's Dealing 2014

Mar 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-03-10

Reporting Person: Tobias Jeffrey K (EVP, Research & Dev and CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-10	Ordinary Shares	M	1281	$46.83	Acquired	49384	Direct
2014-03-10	Ordinary Shares	M	1719	$59.13	Acquired	51103	Direct
2014-03-10	Ordinary Shares	S	3000	$152.99	Disposed	48103	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-10	Nonstatutory Stock Option (right to buy)	$46.83	M	1281	Disposed	2022-08-08	Ordinary Shares (1281)	Direct
2014-03-10	Nonstatutory Stock Option (right to buy)	$59.13	M	1719	Disposed	2023-03-04	Ordinary Shares (1719)	Direct

Footnotes

F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 26,889 shares in twenty-one equal monthly installments from April 9, 2014 to December 9, 2015 and with respect to 9,532 shares in eight equal monthly installments from January 9, 2016 to August 9, 2016.

F3: Following the reported transaction, the remaining ordinary shares subject to this option are vested with respect to 4,531 shares and will vest with respect to 4,687 shares in nine equal monthly installments from April 5, 2014 to December 5, 2014 and with respect to 12,500 shares in twenty-four equal monthly installments from January 5, 2015 to December 5, 2016.